NCT00186303已完成不适用
Autologous and Allogeneic Peripheral Blood Progenitor (PBPC) Transplantation for Patients With Chronic Lymphocytic Leukemia
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 28
- 试验地点
- 2
- 主要终点
- Efficacy
研究概览
简要总结
To evaluate the role of high dose therapy and autologous or allogeneic hematopoietic cell transplantation for the treatment of chronic lymphocytic leukemia.
详细描述
To determine effectiveness of allogeneic transplantation in eradicating chronic lymphocytic leukemia.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 60 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •adequate organ function
- •normal bone marrow cytogenetics
排除标准
- •active CNS disease
- •For autologous patients more than 30% bone marrow involvement
结局指标
主要结局
Efficacy
次要结局
- Feasibility
- Toxicity
- olymerase Chain Reaction (PCR) for minimal residual disease
研究者
Robert Negrin
Professor
Stanford University
研究点 (2)
Loading locations...
相似试验
已完成
不适用
High Dose Chemotherapy Followed By PBSC Rescue for HDHodgkin DiseaseNCT00186251Stanford University200
已完成
2 期
Autologous Bone Marrow Transplantation in Acute Non-Lymphoblastic Leukemia During First or Subsequent RemissionLeukemiaLeukemia, Myelocytic, AcuteBlood and Marrow Transplant (BMT)NCT00186381Stanford University200
已完成
不适用
Allogeneic Blood Stem Cell TransplantationHodgkin's DiseaseNCT00423709M.D. Anderson Cancer Center46
终止
2 期
Donor-specific Allogeneic Hematopoietic Cell Transplantation for Acute Lymphoblastic Leukemia (ALL)Acute Lymphoid LeukemiaNCT01037764Asan Medical Center100
终止
不适用
Allogeneic Hematopoietic Stem Cell Transplantation in HIV-1 Infected PatientsHIV-1 InfectionNCT02732457Kirby Institute5